Ligand Pharmaceuticals | 営業経費





営業経費 変化する 日付
Agenus USD -274.14M 80.46M 2025-09
Amgen USD 5.9B 773M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Enviri Corporation USD 361.08M 15.18M 2025-09
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Glaxosmithkline GBP 7.77B 2.22B 2025-09
Heron Therapeutics USD 38.47M 4M 2024-09
Insmed USD 513.55M 109.86M 2025-12
Intrexon USD 61.56M 26.1M 2024-06
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
MacroGenics USD 67M 8M 2025-09
Merck USD 10.16B 558M 2025-12
Pacira USD 166.36M 4.5M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Veracyte USD 108.76M 7.09M 2025-09


Ligand Pharmaceuticals 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.